AlphaStar Capital Management LLC decreased its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 9.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,341 shares of the financial services provider’s stock after selling 635 shares during the quarter. AlphaStar Capital Management LLC’s holdings in Aflac were worth $566,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Eudaimonia Partners LLC increased its holdings in shares of Aflac by 234.6% in the 4th quarter. Eudaimonia Partners LLC now owns 10,448 shares of the financial services provider’s stock worth $862,000 after purchasing an additional 7,325 shares in the last quarter. Crossmark Global Holdings Inc. increased its holdings in Aflac by 22.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock worth $7,096,000 after buying an additional 15,855 shares in the last quarter. Southeast Asset Advisors Inc. raised its position in Aflac by 0.4% in the 4th quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock worth $11,481,000 after buying an additional 589 shares during the last quarter. Nordea Investment Management AB raised its position in Aflac by 6.7% in the 1st quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock worth $155,140,000 after buying an additional 113,226 shares during the last quarter. Finally, Richard C. Young & CO. LTD. bought a new position in Aflac during the 4th quarter valued at about $12,546,000. Institutional investors own 67.44% of the company’s stock.
Aflac Trading Up 0.1 %
NYSE AFL traded up $0.13 during trading hours on Tuesday, hitting $107.64. 382,593 shares of the company were exchanged, compared to its average volume of 2,213,554. Aflac Incorporated has a 52 week low of $73.62 and a 52 week high of $108.31. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock has a 50-day moving average price of $95.53 and a 200 day moving average price of $88.11. The stock has a market cap of $61.16 billion, a PE ratio of 11.87, a price-to-earnings-growth ratio of 2.76 and a beta of 0.95.
Aflac Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.86%. Aflac’s dividend payout ratio (DPR) is presently 22.08%.
Insider Activity
In other news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.90% of the company’s stock.
Wall Street Analysts Forecast Growth
AFL has been the subject of a number of research analyst reports. Bank of America lifted their price target on shares of Aflac from $105.00 to $108.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Jefferies Financial Group decreased their target price on shares of Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Piper Sandler raised their price target on Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Friday, June 28th. Citigroup upped their price objective on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. Finally, StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $91.69.
View Our Latest Analysis on Aflac
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- Insider Trades May Not Tell You What You Think
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Small-Cap Stocks to Buy and Hold For 2025 and Beyond
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.